Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
To evaluate the effects of oral emixustat hydrochloride (emixustat) on aqueous humor biomarkers associated with proliferative diabetic retinopathy (PDR) from baseline to week 12.
Epistemonikos ID: 4093e97f10e6af5a87576427be9350e61eafcf13
First added on: May 13, 2024